MIF and melanoma: As further validation, the same analysis of an independent dataset of metastatic melanoma tissues (GSE19234;[39]) also indicated significantly worse outcomes for patients whose tumours expressed higher levels of MIF (univariate Cox regression; hazard ratio = 4.600; 95% confidence interval 1.6-12.9; p = 0.004; Figure 7D).